The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index; 34 of the 249 sources its claims cite were checked for support.
Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease
Open accessAbstract
INTRODUCTION: Paracetamol is one of the most used medicines worldwide and is the most common important poisoning in high-income countries. In overdose, paracetamol causes dose-dependent hepatotoxicity. Acetylcysteine is an effective antidote, however despite its use hepatotoxicity and many deaths still occur. AREAS COVERED: This review summarizes paracetamol overdose and toxicity (including mechanisms, risk factors, risk assessment, and treatment). In addition, we summarize the epidemiology of paracetamol overdose worldwide. A literature search on PubMed for poisoning epidemiology and mortality from 1 January 2017 to 26 October 2022 was performed to estimate rates of paracetamol overdose, liver injury, and deaths worldwide. EXPERT OPINION: Paracetamol is widely available and yet is substantially more toxic than other analgesics available without prescription. Where data were available, we estimate that paracetamol is involved in 6% of poisonings, 56% of severe acute liver injury and acute liver failure, and 7% of drug-induced liver injury. These estimates are limited by lack of available data from many countries, particularly in Asia, South America, and Africa. Harm reduction from paracetamol is possible through better identification of high-risk overdoses, and better treatment regimens. Large overdoses and those involving modified-release paracetamol are high-risk and can be targeted through legislative change.
Overview
CoChat Summary
TL;DR
This review summarizes paracetamol overdose mechanisms, risk factors, risk assessment, treatment, prevention measures, and global epidemiology. It estimates that paracetamol is involved in 6% of poisonings, 56% of severe acute liver injury/acute liver failure, and 7% of drug-induced liver injury, with about 0.4% of paracetamol poisoning cases fatal.
Key findings
- Where data were available, paracetamol accounted for a weighted mean of 6.2% of poisonings (range 0.5–34.9%), 55.7% of severe acute liver injury and/or acute liver failure (range 50.0–77.8%), and 7.3% of drug-induced liver injury (range 1.2–29.2%); the case fatality rate for paracetamol poisonings was 0.4% (range 0.1–2.3%).
- Toxicity occurs via NAPQI, formed primarily by CYP2E1 and CYP3A4; when glutathione is depleted, NAPQI binds cellular proteins, causes mitochondrial dysfunction, and leads to hepatocyte necrosis. Acetylcysteine replenishes glutathione and is most effective when given within 8 h of ingestion.
- Major risk factors include massive overdoses (>30 g), modified-release/extended-release paracetamol, delayed presentation, enzyme inducers, malnutrition/fasting, and chronic alcohol use; repeated supratherapeutic ingestion carried higher hepatotoxicity in one US study (52% accidental vs 14% deliberate overdose).
- Prevention evidence includes UK 1998 pack-size restrictions, associated with a 22% reduction in suicidal deaths in the first year sustained for two years, ~30% reductions in liver unit admissions and liver transplants, and a 20% reduction in large overdoses; Denmark’s age and pack-size restrictions reduced poisonings and severity, while early evaluation of Australia’s modified-release up-scheduling found no reduction in MR paracetamol poisonings.
Methods
- Narrative review with two literature searches: a PubMed search for poisoning epidemiology and mortality from 1 January 2017 to 26 October 2022, plus poisons information centre annual reports and email responses; and PubMed/Embase searches from inception to December 2022 for clinical toxicology topics including risk assessment, risk factors, management, and legislative change.
- Epidemiology analysis included 115 data sources: 88 relevant publications, 17 annual reports or statistical information from websites, and data from 10 email responses; weighted averages were calculated using meta-analysis in R 4.0.4, with rates expressed per 100,000 population and/or as a percentage of poisoning exposures where catchment populations were available.
- Case fatality rates were calculated where possible by dividing cause-specific poisoning fatalities by exposures; for clinical sections, the authors used keyword searches, systematic reviews, and citation chaining.
Limitations
- Stated: the PubMed-only search may have missed relevant studies; data were lacking from many countries, particularly in Asia, South America, and Africa; only 11 direct PIC email responses were received, 66 emails were undeliverable, and over 50 websites were inaccessible; definitions for analgesics, DILI, and ALF/ALI were inconsistent; PIC operational models varied; catchment populations were often unavailable; some data covered only certain regions; death data sources have limitations, including missed out-of-hospital deaths and possible over-counting by coronial/forensic data in multi-drug overdoses; pediatric-only data sources were excluded.
- Evident from the text: this is a narrative review rather than a systematic review, and the global estimates rely on heterogeneous observational data and weighted means that may not be internationally representative; no formal risk-of-bias assessment is reported, and several intervention evaluations are observational or lack published outcome data, such as the impact of the EMA suspending modified-release paracetamol.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
17 Valid · 2 Not valid · 114 Not checked · 49 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Overall, paracetamol accounted for a weighted mean of 55.7% (range 50.0-77.8%) of severe acute liver injury (ALI) and/or ALF [201-208] and 7.3% (range 1.2-29.2%) of drug-induced liver injury (DILI) [209-219] (see Figure 7).”
- Also stated in: § 7. Conclusions · hedged
“Where data were available, we estimate it is used in 6% of poisonings, implicated in 56% of cases of severe acute liver injury and acute liver failure and 7% of drug-induced liver injury.”
§ Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism > 5.4. Rates of hepatotoxicity and liver failure
What the sources say
- Partly supportedcites [209] sourceExperimental — accuracy not yet measured
The Results report three confirmed acetaminophen (paracetamol) cases in a Brazilian cohort of patients with acute liver failure, and Table 1 describes 42 confirmed drug-related DILI cases leading to acute liver failure. These data support a small paracetamol contribution in this study, but the paper does not report the cited weighted mean or range across DILI studies; its cohort is limited to liver-transplant patients with acute liver failure. (LLM, conf=0.84)
- Partly supportedcites [210] sourceExperimental — accuracy not yet measured
The Results (Etiology of DILI; page unavailable) report five acetaminophen-caused cases among the 1,096 DILI patients analyzed. This supports including the study as evidence that paracetamol caused some DILI cases, but the paper does not report the cited weighted mean of 7.3% or its 1.2–29.2% range. (LLM, conf=0.87)
- Not checked yetcites [211] source
- Not checked yetcites [212] source
- Partly supportedcites [213] sourceExperimental — accuracy not yet measured
The Causative agents section identifies paracetamol among drugs implicated in DILI in this 82-patient study. It places paracetamol in a group of five drugs accounting for 6% of cases, but does not give a separate paracetamol percentage or report the cited weighted mean and range across studies. (LLM, conf=0.84)
- Not checked yetcites [214] source
- Disputedcites [215] sourceExperimental — accuracy not yet measured
The Patients and methods > Exclusion criteria section says patients with known or suspected acetaminophen toxicity were excluded. Thus this study cannot supply a positive paracetamol share of its DILI cases; it also does not report the cited weighted mean or range. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [216] sourceExperimental — accuracy not yet measured
The ‘Frequently reported suspected and concomitant drugs’ section identifies paracetamol as the most commonly suspected drug in Swiss reports of severe drug-related hepatic disorders. It does not report a weighted mean of 7.3%, a range of 1.2–29.2%, or paracetamol’s share of DILI cases overall. (LLM, conf=0.83)
- Could not verifycites [217] sourceExperimental — accuracy not yet measured
The Results (page unavailable) report 75 acetaminophen hepatotoxicity cases among 257 patients meeting liver-injury criteria, then exclude those cases from the idiosyncratic DILI study sample. Neither the Results nor passages retrieved by searching for the weighted mean and acetaminophen’s proportion of DILI report a 7.3% weighted mean or a 1.2–29.2% range. (LLM, conf=0.76)
- Not checked yetcites [218] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 7. Conclusions · hedged
Every source the paper cites for this claim was checked and supports it.
In the paper
“Repeated supratherapeutic ingestion can cause toxicity in doses only slightly above the maximum daily therapeutic dose [4].”
§ Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism > 1. Introduction
What the sources say
- Supportedcites [4] source
The Discussion (page unavailable) reports liver damage after repeated supratherapeutic ingestion at modest reported daily doses, including some below the recommended daily dose. This supports the claim that toxicity can occur at doses only slightly above the therapeutic maximum. The paper cautions that some reported doses may have been underestimated. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Individuals who are fasting, malnourished, or anorexic are at increased risk for toxicity due to lower glutathione levels [44].”
§ Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism > 3.2.4. Glutathione depletion
What the sources say
- Partly supportedcites [44] sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) identifies fasting and malnutrition as risk factors for acetaminophen-related liver injury and reports increased acute liver injury risk with malnutrition. The Discussion (page unavailable) explains that glutathione helps detoxify an acetaminophen metabolite, but discusses reduced glutathione in relation to HCV or long-term alcohol use—not fasting or malnutrition. The paper does not address anorexia or establish lower glutathione as the reason for the nutritional risk. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“NAC restores glutathione by replenishing cysteine, the ratelimiting factor for glutathione synthesis [96,97].”
§ Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism > 4.2. N-acetylcysteine (NAC)
What the sources say
- Partly supportedcites [96] sourceExperimental — accuracy not yet measured
Our copy supports the first half: the Results ("Specific Activity Of Glutathione Adduct In Bile") report that hepatic glutathione synthesis rose to 2.69 µmol/h per g liver after N-acetylcysteine (vs 0.54 with acetaminophen alone) and that hepatic glutathione concentration "markedly increased," with the Discussion (OCR section "L Aceteminophen In Urine") attributing this to N-acetylcysteine supplying cysteine precursors that do not reenter the pathway after adduct loss. However, the source hedges the rate-limiting claim — cysteine availability "may become the rate-limiting step in glutathione synthesis" (citing ref. 36) only when synthesis is stimulated — so stating it as THE rate-limiting factor overstates it. The same Discussion also declines to credit glutathione restoration alone, arguing N-acetylcysteine additionally reduces the reactive acetaminophen metabolite and raises biliary disulfide excretion, and the Introduction ("N-Acetylcysteine could conceivably protect...") explicitly questions the quantitative importance of the precursor mechanism in vivo. (LLM, conf=0.75)
- Supportedcites [97] source
Section 3 'Mechanism of Molecular Action' (p. ~3) states that intracellular cysteine concentration is lower and 'acts as a limiting factor in the rate of GSH biosynthesis', which 'explains the role of NAC as a prodrug of cysteine and intracellular GSH', and that NAC's antioxidant importance is 'directly linked to its ability to increase levels of intracellular cysteine with subsequent increase in GSH'. Section 4.5 (Liver Diseases) adds that NAC's function is 'to replenish the stocks of GSH', and the Conclusions restate NAC as a precursor to intracellular cysteine increasing the GSH pool. The paraphrase matches on both elements (cysteine replenishment and cysteine as the rate-limiting factor). (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“NAFLD has also been identified as a risk factor for hepatic injury following paracetamol overdose [44].”
§ Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism > 3.2.8. Other risk factors
What the sources say
- Supportedcites [44] source
The Results section (page not available in our copy) reports that diagnosed NAFLD was associated with higher adjusted odds of acute liver injury among patients hospitalized for acetaminophen toxicity (aOR 7.50; 95% CI 3.57–15.7). This supports the cited claim about hepatic injury following paracetamol overdose. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
82 more claims · 7 with their cited sources checked
Create a free account to see all 182 claims and to verify the 215 references still open.
- It may state two separate claims as one. 58
- Probably not a substantial claim. 50
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Global consumption is measured in tens of billions of doses annually, making it one of the most frequently used medications worldwide [ 3 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism > 8. Expert opinion
“Figure 7. Proportion of patients who develop ALI/ALF or DILI after paracetamol use.”
§ Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism > 5.4. Rates of hepatotoxicity and liver failure
“Overall, paracetamol accounted for a weighted mean of 55.7% (range 50.0-77.8%) of severe acute liver injury (ALI) and/or ALF [201-208] and 7.3% (range 1.2-29.2%) of drug-induced liver injury (DILI) [209-219] (see Figure 7).”
Citations
Cites
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227 · cited 1×
“liver transplantation or result in death [9,11].”
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., Reisch, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,926
Mechanisms of Acetaminophen-Induced Liver Necrosis
Hinson, J. A., Roberts, D. W., & James, L. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00663-0_12 · Cited by 1,006 · cited 4×
“Formation of reactive oxygen species causes oxidative stress and leads to activation of c-jun N-terminal kinase (JNK) [23].”
BackgroundInfluentialGraham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., & Proudfoot, A. T. (1979) · BMJ · doi:10.1136/bmj.2.6198.1097 · Cited by 667 · cited 4×
“Before the availability of NAC treatment, morbidity and mortality following paracetamol overdose was considerable; many developed acute liver injury and 3–5% died [99,100].”
BackgroundMethodInfluentialWatkins, P. B., Kaplowitz, N., Slattery, J. T., Colonese, C. R., Colucci, S. V., Stewart, P. W., & Harris, S. C. (2006) · JAMA · doi:10.1001/jama.296.1.87 · Cited by 632
Gummin, D. D., Mowry, J. B., Spyker, D. A., Brooks, D. E., Fraser, M. O., & Banner, W. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1388087 · Cited by 553
N-Acetylcysteine (NAC): Impacts on Human Health
Tenório, M. C. D. S., Graciliano, N. G., Moura, F. A., Oliveira, A. C. M. D., & Goulart, M. O. F. (2021) · Antioxidants · doi:10.3390/antiox10060967 · Cited by 526
Paracetamol (Acetaminophen): mechanisms of action
ANDERSON, B. J. (2008) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2008.02764.x · Cited by 497 · cited 4×
“non-steroidal anti-inflammatory drugs (NSAIDs)), suggesting that it only acts centrally rather than peripherally [17].”
BackgroundInfluential
Research works printed but not linked: 14
- 2021, WHO model list of essential medicines - 22nd list, 2021
- Cahn A, 1886, Centralbl Klin Med, 7, 561
- von Mering J, 1893, Ther Monatsch, 7, 577
- Brodie BB, 1949, J Pharmacol Exp Ther, 97, 58
- Afandiyev I, 2019, Georgian Med News, 287, 105
- Bentur Y, 2019, Isr Med Assoc J, 21, 175
- Babić Ž, 2022, Arh Hig Rada Toksikol, 73, 88
- Boletim CIAV, Centro de Informação Antivenenos Dados Estatísticos 2021 [CIAV Bulletin – Antivenom Information Center Statistical Data 2021]
- Kumpula EK, 2021, N Z Med J, 134, 26
- Khan M, 2019, J Pak Med Assoc, 69, 1025
- Supervía Caparrós A, 2017, Emergencias, 29, 335
- Nugteren-van Lonkhuyzen JJ, 2022, [Acute poisonings in humans and animals - NVIC Annual Review 2021]
- Poisons Standard October 2022, 2022, Canberra
- 1.4. Final decision in relation to paracetamol (modified release) [Internet]
Cited by
NLRP3 inflammasome in hepatic diseases: A pharmacological target
Ramos‐Tovar, E., & Muriel, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115861 · Cited by 75
Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations
Liu, Q., Wang, S., Fu, J., Chen, Y., Xu, J., Wei, W., Song, H., Zhao, X., & Wang, H. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1812 · Cited by 49
“60,61 Excessive APAP exposure damages mitochondria and results in significant DNA harm, resulting in swift cell death during specific phases of the cell cycle and potentially halting the entire process.”
BackgroundChao, X., Niu, M., Wang, S., Ma, X., Yang, X., Sun, H., Hu, X., Wang, H., Li, Z., Huang, R., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.10.017 · Cited by 38
“Acetaminophen (APAP) is a safe and effective drug at therapeutic doses, but an overdose can cause severe liver injury resulting in acute liver failure in animals and man 1 .”
BackgroundUnderlying mechanisms and treatment of acetaminophen‑induced liver injury (Review)
Li, R., Wu, H., Xu, Y., Xu, X., Xu, Y., Huang, H., Lv, X., Liao, C., Ye, J., & Li, H. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13471 · Cited by 43
“Various factors can increase the risk for APAP toxicity, which is mainly mediated by the metabolic pathway of APAP (12).”
Cell Death in Liver Disease and Liver Surgery
Stoess, C., Choi, Y., Onyuru, J., Friess, H., Hoffman, H. M., Hartmann, D., & Feldstein, A. E. (2024) · Biomedicines · doi:10.3390/biomedicines12030559 · Cited by 29
“Drug-induced liver injury or DILI is a significant cause of acute liver injury (ALI) that can ultimately progress to acute liver failure (ALF) [71].”
Background
Metadata
- Authors
- Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R.
- Affiliations
- The University of Sydney (AU)
- Corresponding author
- Cairns, Rose
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2023-05-04
- Volume
- 19
- Issue
- 5
- Pages
- 297-317
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W4384074050
- Cited by
- 215
- References
- 220
- Citations by year
- 2026: 85 · 2025: 76 · 2024: 48 · 2023: 5
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Expert Opinion on Drug Metabolism & Toxicology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Figshare (cc-by)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- acetaminophen overdose, paracetamol, hepatotoxicity, acute liver failure, drug-induced liver injury, N-acetylcysteine, antidote therapy, poisoning epidemiology, drug overdose deaths, harm reduction, over-the-counter analgesics, drug regulation
- MeSH terms
- Acetaminophen, Acetylcysteine, Humans, Cost of Illness, Chemical and Drug Induced Liver Injury, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. https://app.cochat.ai/papers/10.1080/17425255.2023.2223959
- The paper
- Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R. (2023). Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2023.2223959
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.